Activated complement C3: A potentially novel predictor of progressive IgA nephropathy

Zwirner, Jörg; Burg, Michael; Schulze, Matthias; Brunkhorst, Reinhard; Götze, Otto; Koch, Karl-Martin; Floege, Jürgen
April 1997
Kidney International;Apr1997, Vol. 51 Issue 4, p1257
Academic Journal
In the search for a serologic marker of disease activity, we measured concentrations of activated C3 (actC3, that is, neoantigens developing after C3 activation on breakdown products), C4-C3 complexes and soluble C5b-9 (sC5b-9) in one or two plasma samples from adult patients with IgA nephropathy (IgAN, N = 50) or Henoch-Schonlein purpura (HSP, N = 4). As controls, 20 patients with non-immune renal disease, but comparable age, degree of proteinuria, renal dysfunction and prevalence of hypertension were studied. Compared to controls, actC3 levels were elevated in 30% of the patients with IgAN and one of the HSP patients. C4-C3 complexes were elevated in only 8% of the IgAN patients, and sC5b-9 levels were within the control range in all IgAN and HSP patients. In IgAN patients with elevated actC3 levels, proteinuria and hematuria were more pronounced than in those with normal levels. Elevated plasma concentrations of actC3 at the first presentation correlated with subsequent deterioration of renal function both in patients with initially normal and already impaired renal function (r = -0.56, N = 44, P = 0.003). The five IgAN patients with elevated actC3 on both occasions of obtaining plasma showed the most rapid loss of renal function. We conclude that mainly alternative pathway complement activation can be demonstrated in patients with IgAN and HSP. In IgAN patients the presence of complement activation is associated with more severe renal disease. Further studies are warranted to examine the clinical usefulness of actC3 as a predictor of the subsequent course of IgAN.


Related Articles

  • Persistent microhaematuria with negative or low proteinuria. Gutiérrez, Eduardo; Moreno, Juan A.; Praga, Manuel // Nefrologia;2014, Vol. 34 Issue 1, p110 

    The level of proteinuria continues to be the clinical parameter that is best related to the development of long-term renal failure in glomerular pathologies. This quantity is particularly important when we analyse the progression of patients with IgA nephropathy. As such, the natural progression...

  • Proteinuria in IgA nephropathy. Neelakantappa, Kotresha; Gallo, Gloria R.; Baldwin, David S. // Kidney International;Mar1988, Vol. 33 Issue 3, p716 

    Clinicopathological data in 74 patients with IgA nephropathy were analyzed with special attention to level of proteinuria and its prognostic significance in this disease. Excretion rates exceeding 3 g per day (heavy), in the range of 1 to 2.9 g (moderate) and under 1 g per day (mild) each...

  • Immunomorphometric Studies of Proteinuria in Individual Deep and Superficial Nephrons of Rats. Hoyer, John R.; Fogo, Agnes B.; Terrell, Coleman H.; Delaney, Margaret M. // Laboratory Investigation (00236837);Nov2000, Vol. 80 Issue 11, p1691 

    Heterogeneity of structure and function among nephrons is a well-recognized feature of chronic renal diseases. However, only a small number of superficial nephrons per kidney are accessible for micropuncture analysis and relationships of proteinuria to structural change in individual nephrons of...

  • Steroids in the Treatment of IgA Nephropathy to the Improvement of Renal Survival: A Systematic Review and Meta-Analysis. Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He // PLoS Clinical Trials;Apr2011, Vol. 8 Issue 4, Special section p1 

    Background: Studies have shown that steroids can improve kidney survival and decrease the risk of proteinuria in patients with Immunoglobulin A nephropathy, but the overall benefit of steroids in the treatment of Immunoglobulin A nephropathy remains controversial. The aim of this study was to...

  • IgA nephropathy in a patient presenting with scleritis. Teixeira, Catarina; Quintas, Ana Miguel; Lopes, José António; Miranda, Margarida; de Almeida, Edgar // NDT Plus;Oct2010, Vol. 3 Issue 5, p453 

    Scleritis is a very uncommon manifestation in patients with IgA nephropathy. Here, we report the case of a patient presenting with diffuse anterior scleritis in which the laboratory disclosed microscopic haematuria and nephrotic range proteinuria. Renal function was normal. Serology for lupus,...

  • Immunoregulatory factors in the pathogenesis of IgA nephropathy. Emancipator, Steven N. // Kidney International;Dec1990, Vol. 38 Issue 6, p1216 

    The article presents information on two medical cases related to pathogenesis of IgA nephropathy (IgAN). The first phase of investigation of IgAN consists of a descriptive collation of clinical and/or pathologic features. Nearly all patients with IgAN (95%) have hematuria sometime during the...

  • Isolated proteinuria in asymptomatic patients. Robinson, Roscoe R. // Kidney International;Sep1980, Vol. 18 Issue 3, p395 

    Discusses the case of a 38-year-old man who was evaluated at the Duke University Medical Center in Durham, North Carolina, for routine followup of known proteinuria for 19 years. Qualitative proteinuria; Results of physical and laboratory examinations; Diagnostic and prognostic uncertainty...

  • A stepwise approach to evaluating proteinuria. Thorp, Micah L.; Russell, Julia M. // Patient Care;Feb2005, Vol. 39 Issue 2, p37 

    Provides information on evaluating proteinuria. Quantitative measures of protein excretion; Causes of proteinuria; Analysis of protein levels in urine. INSET: Article at a glance.

  • Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0?g/day. Suzuki, Takayuki; Yamamoto, Tatsuo; Ohura, Masaharu; Fujigaki, Yoshihide; Yonemura, Katsuhiko; Kimura, Masato; Hishida, Akira // Clinical & Experimental Nephrology;Sep2004, Vol. 8 Issue 3, p243 

    Background. We investigated the clinical and pathological findings relevant to the efficacy of corticosteroid treatment in IgA nephropathy patients with 0.5 to 2.0 g/day of proteinuria at the initiation of corticosteroid treatment. Methods. In 27 IgA nephropathy patients who received 2-year...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics